In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Replimune Group Inc (NASDAQ: REPL) closed the day trading at $8.40 down -13.85% from the previous closing price of $9.75. In other words, the price has decreased by -$13.85 from its previous closing price. On the day, 1.36 million shares were traded. REPL stock price reached its highest trading level at $9.68 during the session, while it also had its lowest trading level at $8.36.
Ratios:
For a better understanding of REPL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.43 and its Current Ratio is at 11.43. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on August 28, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On November 19, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $52.Piper Sandler initiated its Overweight rating on November 19, 2021, with a $52 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’24 when Patel Sushil sold 10,000 shares for $12.42 per share. The transaction valued at 124,200 led to the insider holds 202,014 shares of the business.
Sushil Patel bought 15,000 shares of REPL for $188,550 on Dec 16 ’24. On Nov 18 ’24, another insider, Xynos Konstantinos, who serves as the Chief Medical Officer of the company, sold 7,246 shares for $10.78 each. As a result, the insider received 78,112 and left with 109,885 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 646924288 and an Enterprise Value of 186426160.
Stock Price History:
The Beta on a monthly basis for REPL is 1.26, which has changed by 0.1898017 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $4.92. The 50-Day Moving Average of the stock is -33.08%, while the 200-Day Moving Average is calculated to be -26.06%.
Shares Statistics:
Over the past 3-months, REPL traded about 722.41K shares per day on average, while over the past 10 days, REPL traded about 855320 shares per day. A total of 77.01M shares are outstanding, with a floating share count of 61.87M. Insiders hold about 19.67% of the company’s shares, while institutions hold 88.68% stake in the company. Shares short for REPL as of 1741910400 were 9546116 with a Short Ratio of 13.21, compared to 1739491200 on 9079342. Therefore, it implies a Short% of Shares Outstanding of 9546116 and a Short% of Float of 17.09.
